Robin Dowell is an Associate Professor in Molecular, Cellular, and Developmental Biology and Computer Science at University of Colorado Boulder. Dr. Dowell is also co-founder of the Boulder biotech startup Arpeggio Biosciences and holds a patent for the assessment of transcription factor activity.
In the human genome, the majority of disease-associated mutations reside within regulatory regions, but how these mutations lead to disease is not well understood. To tackle this problem, Dr. Dowell uses computational biology and molecular genetics to decipher transcription regulation and the activity of transcription factors, the major drivers of regulation. In addition to pursuing translational research activities, Dr. Dowell is a dedicated educator focused on bringing bioinformatics and data science initiatives to the University of Colorado Boulder campus.
Dowell earned two bachelor’s degrees (Computer Engineering and Genetics) from Texas A&M University, a D.Sc. in Biomedical Engineering from Washington University in St Louis, and did postdoctoral research at MIT. She is a member of the Linda Crnic Institute and a Boettcher Investigator.